Related by context. All words. (Click for frequent words.) 73 leucovorin 73 docetaxel chemotherapy 72 gemcitabine 72 docetaxel 71 oxaliplatin 70 idarubicin 70 carboplatin paclitaxel 70 Fludara 69 carboplatin 69 temozolomide 69 rituximab 68 topotecan 68 etoposide 68 low dose cytarabine 68 monotherapy 68 daunorubicin 68 dacarbazine 67 vinorelbine 67 docetaxel Taxotere 67 cyclophosphamide 67 CHOP chemotherapy 67 5 fluorouracil 67 5 FU 66 doxorubicin 66 sorafenib Nexavar 66 paclitaxel 66 pegylated liposomal doxorubicin 66 cetuximab 66 paclitaxel chemotherapy 66 cisplatin 66 mitoxantrone 66 bevacizumab 66 bendamustine 66 5FU 66 HGS# 65 chlorambucil 65 bortezomib 65 sorafenib Nexavar ® 65 fluconazole 65 FOLFOX 65 capecitabine 65 pemetrexed 65 decitabine 65 fludarabine 65 gemcitabine chemotherapy 65 standard chemotherapy regimen 65 pegylated interferon alpha 64 FOLFIRI 64 methotrexate 64 Peg IFN 64 pertuzumab 64 NRTIs 64 estramustine 64 interferon 64 pegylated interferon 64 cytarabine daunorubicin 64 melphalan 64 G CSF 64 cytotoxic chemotherapy 64 erlotinib Tarceva ® 64 vincristine 64 irinotecan 64 dexamethasone Decadron 64 azathioprine 64 interferon alfa 2a 64 standard chemotherapy regimens 64 azacitidine 64 cisplatin chemotherapy 64 Jevtana 63 trastuzumab 63 plus ribavirin 63 sorafenib 63 fluorouracil 63 Pegasys ® 63 adriamycin 63 nab paclitaxel 63 mapatumumab 63 temsirolimus 63 VNP#M 63 amphotericin B 63 refractory AML 63 Taxotere ® 63 DMARDs 63 alkylating agent 63 sunitinib 63 chemotherapeutic regimen 63 lamivudine 63 interferon alfa 2b 63 Folfox 63 Ribavirin 63 pharmacologically active isomer 63 imatinib 63 dose cytarabine 63 metastatic renal cell carcinoma 63 sunitinib malate 63 doxorubicin cyclophosphamide 63 capecitabine Xeloda R 62 ixabepilone 62 Taxotere 62 mycophenolate mofetil 62 docetaxel Taxotere ® 62 nilotinib 62 #mg/m# [001] 62 tenofovir emtricitabine 62 nucleoside analogs 62 5-FU/LV 62 pegylated interferon alfa 2a 62 HER2 positive metastatic breast 62 bevacizumab Avastin 62 erlotinib 62 chemoradiation 62 dasatinib 62 paclitaxel Taxol ® 62 Tarceva erlotinib 62 dexamethasone 62 protease inhibitor PI 62 Irinotecan 62 trastuzumab Herceptin R 62 trabectedin 62 Pegasys peginterferon alfa 2a 62 dose dexamethasone 62 alfa 2a 62 cyclophosphamide methotrexate 62 chemotherapy regimens 62 DOXIL 62 vandetanib 62 DMARD 62 Cloretazine R VNP#M 62 Doxil ® 62 DMARDS 62 relapsed CLL 62 docetaxel Taxotere R 62 gemcitabine Gemzar 62 5 FU leucovorin 62 chemotherapeutic drug 61 Cloretazine 61 Cisplatin 61 pegylated interferon alfa 61 pegfilgrastim 61 relapsed refractory multiple myeloma 61 Herceptin trastuzumab 61 Copegus ribavirin 61 interferon alpha 61 calcineurin inhibitors 61 Doxil 61 VELCADE melphalan 61 YONDELIS 61 gemcitabine Gemzar ® 61 taxane chemotherapy 61 abacavir lamivudine 61 cetuximab Erbitux ® 61 tenofovir Viread 61 chemotherapeutic agents 61 taxane 61 nucleoside analogue 61 Gemzar ® 61 5 fluorouracil leucovorin 61 chemotherapies 61 remission induction 61 gemcitabine carboplatin 61 ribavirin RBV 61 Gemcitabine 61 TELCYTA 61 paclitaxel Taxol 61 pomalidomide 61 TELINTRA 61 Pemetrexed 61 epirubicin 61 relapsed refractory 61 Cytoxan 61 active comparator 61 oblimersen 61 peginterferon alfa 2b 61 galiximab 61 goserelin 61 immunomodulatory therapy 61 APTIVUS 61 ceftriaxone 61 lapatinib Tykerb 61 bortezomib Velcade R 61 cyclophosphamide doxorubicin vincristine 61 imatinib Gleevec 61 sapacitabine 61 celgosivir 61 Panzem R NCD 61 interferon alfa 61 rituximab Rituxan 61 imipenem 61 cell lymphoma CTCL 61 XELOX 61 enzastaurin 61 Taxotere docetaxel 61 plus dexamethasone 61 amrubicin 61 plus prednisone 61 Cytarabine 61 palifosfamide 61 sorafenib Nexavar R 61 capecitabine Xeloda 61 AGILECT R 61 epoetin alfa 61 mitomycin 60 tyrosine kinase inhibitor 60 idraparinux 60 immunosuppressant 60 forodesine 60 nucleoside reverse transcriptase inhibitor 60 leukemia AML 60 PREZISTA r 60 infusional 5-FU/LV 60 lopinavir r 60 paclitaxel carboplatin 60 chemotherapeutic regimens 60 indolent NHL 60 chemoradiotherapy 60 DAPT 60 Imprime PGG 60 Amrubicin 60 zalutumumab 60 chemotherapeutics 60 methotrexate MTX 60 Torisel 60 lenalidomide 60 arsenic trioxide 60 irbesartan 60 L asparaginase 60 pyrazinamide 60 platinum refractory 60 TORISEL 60 lenalidomide Revlimid R 60 cilengitide 60 Hycamtin ® 60 paclitaxel cisplatin 60 q8h 60 certolizumab 60 dasatinib Sprycel ® 60 ara C 60 Platinol 60 trans retinoic acid ATRA 60 GRN#L 60 refractory cutaneous T 60 bevacizumab Avastin ® 60 FluCAM 60 pegylated 60 heavily pretreated 60 APTIVUS r 60 intravenous cyclophosphamide 60 chemotherapy docetaxel 60 ribavirin 60 peginterferon 60 pamidronate 60 HGS ETR1 60 Pegasys plus Copegus 60 heavily pretreated patients 60 cutaneous T 60 axitinib 60 vorinostat 60 darunavir ritonavir 60 Oxaliplatin 60 Telintra 60 Taxotere R 60 LEXIVA r 60 Tarceva TM 60 iniparib 60 Pertuzumab 60 clodronate 60 ritonavir boosted 60 CANCIDAS 60 tyrosine kinase inhibitors 60 chemotherapeutic agent 59 overlapping toxicities 59 3TC lamivudine Epivir 59 Xanafide 59 gemcitabine cisplatin 59 imatinib resistant 59 lapatinib 59 PegIFN RBV 59 mg m² 59 refractory metastatic colorectal cancer 59 melphalan prednisone 59 irinotecan chemotherapy 59 xanthine oxidase inhibitor 59 IMC A# 59 Bevacizumab 59 Bortezomib 59 systemic ALCL 59 evaluating tivozanib 59 bleomycin 59 lenalidomide dexamethasone 59 CIMZIA TM 59 CA4P 59 Trastuzumab 59 Rituxan rituximab 59 timolol 59 low dose dexamethasone 59 Docetaxel 59 bevacizumab Avastin R 59 oral levofloxacin 59 boosted protease inhibitor 59 formoterol fumarate 59 cytotoxic 59 telaprevir dosed 59 chronic lymphocytic leukemia CLL 59 Gleevec resistant 59 peginterferon alfa 59 Fludarabine 59 irinotecan doxorubicin oxaliplatin paclitaxel 59 leukemia CLL 59 anti TNF 59 cetuximab Erbitux R 59 piperacillin tazobactam 59 plus prednisone prednisolone 59 uric acid lowering 59 refractory NSCLC 59 chemotherapy cisplatin 59 granisetron 59 budesonide 59 oxaliplatin Eloxatin 59 octreotide 59 FOLFOX4 59 anti leukemic 59 Rituxan MabThera 59 Hycamtin 59 advanced NSCLC 59 refractory chronic lymphocytic 59 amodiaquine 59 raltegravir 59 T DM1 59 peg IFN 59 dasatinib Sprycel 59 dose regimens 59 LHRH agonists 59 dose cohorts 59 comparator arm 59 anti TNF alpha 59 adalimumab Humira 59 fluoropyrimidine 59 nitazoxanide 59 Allovectin 7 ® 59 intermittent dosing 59 Interferon alfa 59 FOLFOX6 chemotherapy regimen 59 Peginterferon 59 chemotherapy regimen 59 COPEGUS 59 vicriviroc 59 zidovudine 59 Sanofi Aventis Taxotere 59 Epirubicin 59 Elotuzumab 59 relapsed multiple myeloma 59 sargramostim 59 selegiline 59 mRCC 59 LEP ETU 59 FOLFOX chemotherapy 59 TNF inhibitor 59 liposomal doxorubicin 59 azacytidine 59 metastatic hormone refractory 59 immunomodulator 59 imatinib therapy 59 fluticasone propionate 59 TKIs 59 zoledronic acid 59 plus gemcitabine 59 peginterferon alfa 2a 59 subcutaneously administered 59 rHuPH# 59 adefovir 59 AEG# 58 conventional DMARDs 58 mTOR inhibitors 58 protease inhibitor 58 pegylated interferons 58 REOLYSIN ® 58 cytotoxic agents 58 tanespimycin 58 doxorubicin docetaxel 58 Rituximab 58 fosamprenavir 58 #mg/m# [002] 58 administered subcutaneously 58 interferon ribavirin 58 TACE 58 Navelbine 58 zidovudine lamivudine 58 paclitaxel Taxol R 58 Alkeran 58 aflibercept 58 Mitoxantrone 58 Erlotinib 58 Topotecan 58 Epivir 58 Camptosar ® 58 sorafenib tablets 58 weekly subcutaneous injections 58 temsirolimus Torisel ® 58 fulvestrant 58 aflibercept VEGF Trap 58 taxotere 58 sevelamer 58 ceftazidime 58 biologic therapy 58 granulocyte colony stimulating 58 refractory acute myeloid 58 adecatumumab 58 potent CYP#A# inhibitors 58 milatuzumab 58 MGd 58 relapsed acute myelogenous 58 bosutinib 58 alvespimycin 58 Aptivus ® 58 nelfinavir 58 teriflunomide 58 relapsed MM 58 intravenously administered 58 eribulin 58 interferons 58 DOXIL ® 58 fluticasone 58 disease modifying antirheumatic 58 Doxorubicin 58 resistant ovarian cancer 58 IFN alpha 58 dose regimen 58 oral rivaroxaban 58 Capecitabine 58 Sinemet 58 peginterferon alpha 2a 58 DMARD therapy 58 allopurinol 58 TTF Therapy 58 relapsed ovarian cancer 58 maximally tolerated dose 58 nucleoside analogues 58 postoperative chemotherapy 58 corticosteroid dexamethasone 58 4mg/kg 58 talabostat 58 pan HDAC inhibitor 58 NNRTIs 58 temozolomide TMZ 58 calcineurin inhibitor 58 oral antiviral 58 imatinib Gleevec ® 58 adalimumab 58 partial remissions 58 dosing schedules 58 Lenalidomide 58 echinocandin 58 Seliciclib 58 visilizumab 58 tigecycline 58 Paclitaxel 58 NXL# 58 CLORETAZINE TM VNP#M 58 cabazitaxel 58 metformin 58 Cloretazine ® 58 Methotrexate 58 LPV r 58 Temsirolimus 58 meropenem 58 Velcade bortezomib 58 BAY #-# 58 cediranib 58 FOLFOX6 58 Vincristine 58 basiliximab 58 mg/m2/day 58 nucleoside reverse transcriptase inhibitors 58 hepatic metastases 58 dosing regimens 58 Roche Chugai s 58 ganciclovir 58 luteinizing hormone releasing 58 salmeterol fluticasone 58 Etoposide 58 neratinib 58 potentially hepatotoxic 58 mometasone furoate 58 lamivudine zidovudine 58 peg interferon 58 elacytarabine 58 Genasense 58 carboplatin chemotherapy 58 DEB# 58 tolerability 58 PEG IFN 58 Carboplatin 58 INTELENCE 58 MIRCERA 58 TAXOTERE R 58 subcutaneous formulation 58 neurologic progression 58 FOLFOX regimen 58 veltuzumab 58 interferon gamma 1b 58 ELOXATIN 58 generation purine nucleoside 58 concurrent chemoradiation 58 taxol 58 refractory multiple myeloma 58 clofarabine 58 atazanavir 57 elotuzumab 57 glatiramer acetate 57 IFN beta 57 alpha 2b 57 tocilizumab 57 glufosfamide 57 tenofovir DF 57 polymerase inhibitor 57 EFAPROXYN 57 Xeloda capecitabine 57 cyclophosphamide Cytoxan 57 tobramycin 57 metformin HCl 57 ethambutol 57 romidepsin 57 μg dose 57 amprenavir 57 metastatic HRPC 57 voreloxin 57 Ceflatonin 57 Taxol paclitaxel 57 Mylotarg 57 posaconazole 57 mometasone 57 lupus nephritis 57 gefitinib 57 motesanib 57 calcitriol 57 metastatic colorectal cancer 57 basal insulin 57 voriconazole 57 CellCept 57 follicular NHL 57 tinidazole 57 Ph + ALL 57 INCB# [001] 57 clopidogrel Plavix 57 antiandrogen 57 nucleoside analog 57 Alocrest 57 stavudine 57 thalidomide Thalomid 57 oral chemotherapeutic agent 57 REVLIMID lenalidomide 57 proton pump inhibitor PPI 57 Caelyx 57 vancomycin 57 cisplatin gemcitabine 57 Peginterferon alfa 2b 57 Revlimid lenalidomide 57 tazobactam 57 methotrexate therapy 57 TNFerade 57 Tamibarotene 57 cobicistat 57 clopidogrel 57 placebo dexamethasone 57 ofatumumab 57 metastatic GIST 57 Fludara ® 57 TKI therapy 57 Pegylated interferon 57 KRAS wild 57 Ixempra 57 zoledronate 57 IMGN# 57 COMBIVIR 57 Nexavar ® 57 FUSILEV enhances 57 REYATAZ R 57 aprepitant 57 hypomethylating agents 57 PegIFN 57 angiogenesis inhibitor 57 8mg/kg 57 TroVax ® 57 metastatic CRC 57 follicular non 57 alpha 2a 57 intravenous bisphosphonates 57 PEG Interferon lambda 57 Gemzar 57 taxanes 57 continuous intravenous infusion 57 mCRC patients 57 anticancer therapy 57 Arixtra 57 IFN alfa 57 chemotherapy gemcitabine 57 velaglucerase alfa 57 CoFactor 57 Lamivudine 57 NRTI 57 integrase inhibitor 57 mCRC 57 Pegylated Interferon 57 MAGE A3 ASCI 57 Gemzar gemcitabine 57 TNF inhibitors 57 TRIZIVIR 57 evaluating Xcytrin 57 tenofovir disoproxil fumarate 57 Dacogen injection 57 tiotropium 57 liposomal formulation 57 entecavir 57 antithrombotics 57 AZILECT 57 degarelix 57 CD# antibody [001] 57 anthracycline taxane 57 stavudine d4T 57 platelet inhibitor 57 seliciclib 57 chronic myeloid leukemia CML 57 atypical antipsychotic 57 antiretroviral regimens 57 TREANDA 57 erlotinib Tarceva 57 sirolimus eluting stent 57 complete remissions 57 eribulin mesylate 57 AZT zidovudine Retrovir 57 alpha interferon 57 TYKERB 57 CVP chemotherapy 57 ISENTRESS 57 taxane refractory 57 Gefitinib 57 ritonavir boosted atazanavir 57 BMS # 57 #mg dose [003] 57 thiazide diuretic 57 Vectibix 57 Vidofludimus 57 Filgrastim 57 Vidaza 57 Rituxan 57 mg kg dose 57 ribavirin therapy 57 lopinavir 57 HGS ETR2 57 neoadjuvant chemotherapy 57 #mg doses [002] 57 LIALDA 57 biologic DMARD 57 caspofungin 57 Pegasys R 57 injected subcutaneously 57 antimetabolite 57 mcg kg 57 Degarelix 57 salmeterol 57 anakinra 57 #mg tablet [001] 57 relapsed SCLC 57 peginterferon alfa 2a Pegasys 57 Camptosar 57 ELACYT 57 nucleoside 57 Phase Ib II 57 inhibitor RG# 57 unfractionated heparin 57 nadolol 57 Xelox 57 AVASTIN 57 pioglitazone HCl 57 bortezomib Velcade 57 chemotherapeutic drugs 57 fondaparinux 57 oral allopurinol 57 crizotinib PF # 57 Elitek 56 Arsenic trioxide 56 levofloxacin 56 palonosetron 56 Melphalan 56 hormone refractory prostate cancer 56 IMP# 56 cytokine refractory 56 dose ritonavir 56 levosimendan 56 Platinol ® cisplatin 56 MYCAMINE 56 olmesartan 56 amoxicillin clavulanate 56 trandolapril 56 oral clodronate 56 lanreotide 56 cyclophosphamide chemotherapy 56 BCR ABL inhibitor 56 OPAXIO 56 mitoxantrone plus 56 doxorubicin HCl liposome injection 56 recurrent GBM 56 de novo kidney transplant 56 afatinib 56 5 Fluorouracil 56 Ontak 56 therapeutic regimens 56 phase IIb clinical 56 AKT inhibitor 56 PSMA ADC 56 hematologic malignancies 56 pegylated interferon alfa 2b 56 etanercept 56 intravesical 56 rifapentine 56 dacetuzumab 56 Sandostatin LAR 56 HuMax CD4 56 FOLPI 56 saline placebo 56 immunosuppressive agents 56 Vidaza azacitidine 56 oral vancomycin 56 Interferon alpha 56 folinic acid 56 vinorelbine tartrate 56 Gleevec imatinib 56 levodopa 56 Omacetaxine mepesuccinate 56 H#N# antigen 56 rilpivirine 56 arsenic trioxide ATO 56 Xeloda ® 56 Dasatinib 56 immunosuppressives 56 anticonvulsant 56 CBLC# 56 OADs 56 tipranavir 56 flutamide 56 carbidopa 56 GVAX 56 interferon α 56 refractory chronic myeloid 56 untreated multiple myeloma 56 camptothecin 56 thymalfasin 56 administered intravenously 56 trabedersen 56 doxorubicin Adriamycin 56 Telcyta 56 Tasigna nilotinib 56 neoadjuvant 56 dacarbazine DTIC 56 RG# [001] 56 randomized multicenter Phase III 56 adjuvant 56 ritonavir boosted lopinavir 56 receptor tyrosine kinase inhibitor 56 valopicitabine 56 Ceplene/IL-2 56 rituximab Rituxan ® 56 Treanda 56 CAELYX 56 TNF alpha inhibitor 56 LY# [003] 56 interferon IFN 56 ACTEMRA TM 56 mg/m2 56 TEMODAL 56 chemotherapy fludarabine 56 Zolinza 56 Navelbine ® 56 farletuzumab 56 infliximab monotherapy 56 primary hypercholesterolemia 56 NRTI backbone 56 ganetespib 56 PEG interferon 56 Omacetaxine 56 octreotide LAR 56 lopinavir ritonavir 56 Paraplatin ® 56 viral kinetics 56 BARACLUDE ® 56 Campath alemtuzumab 56 epirubicin cyclophosphamide 56 metaglidasen 56 recurrent glioblastoma multiforme 56 alpha interferons 56 Femara letrozole 56 Voreloxin 56 novel VDA molecule 56 Targretin 56 dapsone 56 Taxol ® 56 MyVax R 56 hematologic toxicity 56 monotherapies 56 refractory indolent non 56 darunavir 56 romiplostim 56 imiglucerase 56 NNRTI 56 Gleevec imatinib mesylate 56 neoadjuvant therapy 56 BEACOPP 56 ADP receptor antagonist 56 glargine 56 SUTENT 56 TNF alpha inhibitors 56 belinostat 56 Vandetanib 56 mcg dose 56 cutaneous T cell 56 Clofarabine 56 KRAS mutations occur 56 levodopa carbidopa 56 lanthanum carbonate 56 lispro 56 cytogenetic response 56 trastuzumab Herceptin 56 rhGH 56 IXEMPRA 56 Natalizumab 56 fluticasone furoate 56 mitoxantrone chemotherapy 56 anti mitotic 56 mg/m2 administered 56 omega interferon 56 vinca alkaloid 56 Taxotere chemotherapy 56 systemic antifungal 56 paricalcitol 56 acute leukemias 56 fluticasone salmeterol 56 TMC# r 56 PREZISTA rtv 56 cisplatin vinorelbine 56 efavirenz Sustiva 56 unresectable 56 Combination therapy 56 sulphonylurea 56 Xcytrin 56 isoniazid 56 IMA# 56 infusional 56 angiotensin converting enzyme inhibitors 56 relapsing multiple sclerosis 56 ritonavir 56 MabThera Rituxan 56 unique alkylating agent 56 chemotherapy FOLFOX 56 mTOR inhibitor 56 TRISENOX 56 oral ribavirin 56 anticancer agent 56 Neulasta ® 56 sirolimus 56 dose escalation trial 56 Chemophase 56 PEGINTRON 56 imatinib mesylate 56 OXi# 56 everolimus tablets 56 cisplatin carboplatin 56 EndoTAG TM -1 56 anticancer therapies 56 Ganciclovir 56 phenoxodiol 56 entacapone 56 bone metastases 56 TBC# 56 Raltegravir 56 VICTRELIS 56 antitumor activity 56 radiation chemoradiation 56 MYLOTARG 56 bexarotene 56 durable remissions 56 SCCHN 56 Cremophor 56 regorafenib 56 Preclinical studies suggest 56 Tekamlo 56 microtubule inhibitor 56 Avastin 56 Erbitux cetuximab 56 Ampicillin 56 Paraplatin ® carboplatin 56 EGFR expressing mCRC 56 cyclophosphamide FC 56 chemotherapeutic 56 antiviral activity 56 nucleotide analog 56 Nexavar sorafenib 56 recurrent malignant glioma 56 Hepsera 56 Leucovorin 56 fluorouracil leucovorin 56 Cefazolin 56 epoetin 56 PROCRIT 56 telaprevir 56 KRAS mutant tumors 56 ISTODAX 56 denileukin diftitox 56 Avastin bevacizumab 56 panitumumab 56 pegylated liposomal doxorubicin PLD 56 fibrinolytic 56 APTIVUS R 56 figitumumab 56 rFSH 56 strontium ranelate 56 PXD# 56 pimozide 55 metastatic colorectal carcinoma 55 refractory CTCL 55 PegIntron 55 gastrointestinal stromal tumors GIST 55 Pegintron 55 EOquin TM 55 zidovudine AZT 55 VPRIV 55 Xeloda 55 octreotide acetate 55 Traficet EN 55 lenalidomide Revlimid 55 3TC 55 Triapine R 55 carmustine 55 MabCampath 55 Pharmacokinetics PK 55 trastuzumab Herceptin ® 55 relapsed myeloma 55 nilotinib Tasigna ® 55 IMiDs 55 infliximab Remicade 55 Isentress raltegravir 55 imetelstat 55 follicular lymphoma FL 55 daily subcutaneous injections 55 pharmacokinetic interactions 55 K ras mutations 55 intramuscularly 55 huN# DM1 55 Elvitegravir 55 prednisone CHOP 55 panobinostat 55 TRISENOX ® 55 Annamycin 55 Vidaza ® 55 dirucotide MBP# 55 chlorthalidone 55 miconazole Lauriad ® 55 mesalamine 55 tiotropium bromide 55 PEG INTRON R 55 interferon beta 1a 55 Phase III randomized controlled 55 AMN# [001] 55 cytostatic 55 efalizumab 55 dosage regimens 55 advanced unresectable 55 aminoglycoside 55 Hydrochlorothiazide 55 entinostat 55 rALLy clinical trial 55 low dose ritonavir 55 N acetylcysteine 55 lumiliximab 55 VELCADE 55 sevelamer carbonate 55 TMC# [001] 55 phase IIb trial 55 FTY# fingolimod 55 cangrelor 55 OncoVEX GM CSF 55 free survival PFS 55 TMP SMX 55 Leukine ® 55 Rebif ® 55 #mg BID [003] 55 ZOLINZA 55 doxazosin 55 daclizumab 55 aliskiren amlodipine 55 cytogenetic responses 55 cidofovir 55 microwave hyperthermia 55 subcutaneous SC 55 Phase 1b trial 55 adjuvant therapy 55 LMWH 55 #mg QD [002] 55 tipranavir r 55 pazopanib